Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    0.00 (0.00%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.53m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Quarterly Syndicate Mid-point Forecasts

26 Aug 2025 07:00

RNS Number : 6258W
Helios Underwriting Plc
26 August 2025
 

26th August 2025

 

Helios Underwriting plc

('Helios' or 'the Company')

 

Quarterly Syndicate Mid-point Forecasts

 

 

Helios Underwriting, the only publicly traded company offering instant access to a diverse portfolio of syndicates at Lloyd's of London, the world's largest insurance market, announces the current mid-point forecasts in respect of its portfolio of syndicate capacity for the 2023 and 2024 years of account based on second quarter 2025 mid-point forecasts.

 

John Chambers, Interim Executive Chairman, commented:

 

"The continuing strong financial performance of Helios reflects the strength of our unique proposition, our continued strategic delivery and favourable underwriting conditions. As a result, we have been able to continue to unlock shareholder returns, including a dividend payment of 10 pence per share in 2025."

 

"The period has been characterised by an increasingly disciplined approach to the allocation of capital - prioritising established syndicates with profitable track records over new syndicates - while making headway in bringing our operational costs down to a more sustainable level.

 

"We believe that the best years of this insurance cycle remain ahead of us from a returns perspective. Our portfolio management team has worked to increase the quality of Helios' syndicate portfolio, which will show through in future years. Meanwhile, the Lloyd's three-year accounting structure provides the Company with good visibility for the next two years, where we expect to see a similar level of capital returned to Shareholders."

 

2023

2024

2025

 

£m

£m

£m

Total capacity as at 22nd August 2025

 

Retained

251.7

403.5

322.6

Reinsured

66.3

115.2

158.3

 

318.0

518.7

490.9

Mid-point forecast at 31st March 2025

15.2%

7.6%

Current mid-point forecast (30th June 2025)

 

15.6%

8.0%

Change in mid-point forecast

0.4%

0.4%

 

 

Activity During the Period

 

The 2023 mid-point forecast continues to improve to 15.6% (15.2% as at Q1 2025) in line with expectations. Historic development patterns would indicate that further improvement is likely in the final half year.

 

The 2024 calendar year experienced above average levels of catastrophe losses and whilst the significant California wildfires occurred at the start of this year the majority of claims fall back to the 2024 year of account. In spite of this the mid-point forecast at 8.0% profit on capacity (7.6% as at Q1 2025), has improved and the year is tracking towards a strong ultimate result. This demonstrating the underlying strength of pricing adequacy.

 

 

 

 

Notes

1) The table above shows the capacity as at 22nd August 2025, splitting the capacity retained by Helios and the capacity that is ceded to quota share reinsurers and third-party participants. 

2) The mid-point forecasts for 2023 and 2024 years of account as at second quarter 2025 have been aggregated at syndicate level from estimates supplied by Managing Agents.

3) Helios mid-points forecasts have been adjusted for additional expenses charged on syndicates 1902 & 1988, outside the results reported by Lloyd's.

4) Helios mid-points forecasts include estimated profit for seven Syndicate in a Box (SIAB's) supported for the 2024 YOA. These estimates are not included in the market results reported by Lloyd's.

 

For further information, please contact:

Helios Underwriting plc

John Chambers - Interim Executive Chairman +44 (0)203 965 6441 

Adhiraj Maitra - Director of Finance and Operations +44 (0) 203 743 2114

 

Deutsche Numis (Nomad and Broker)

Giles Rolls / Charles Farquhar +44 (0)20 7601 6100

 

FTI Consulting

Ed Berry +44 (0)7703 330 199

Nathan Hambrook-Skinner +44 (0)7977 817 092

Christian Harte +44 (0)7974 288 763

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market. The portfolio provides a broad spread of business primarily participating in the US and other international wholesale and reinsurance markets. For further information please visit www.huwplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUQCRUPAGBA
Date   Source Headline
5th Jun 20264:05 pmRNSGrant of LTIP Award
5th Jun 20267:00 amRNSGrant of LTIP Awards
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSFinal Results for the year ended 31 December 2025
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTR-1 announcement
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTR-1: Acquisition of Voting Rights
21st Apr 20267:00 amRNSChange of Nominated Adviser
20th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20265:17 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSQuarterly Syndicate Mid-point Forecast update
20th Jan 20267:00 amRNS2026 YOA Portfolio Update
9th Jan 20267:00 amRNSAppointment of Chief Underwriting Officer
4th Dec 20255:42 pmRNSGrant of LTIP Awards
2nd Dec 20257:00 amRNSNet Asset Value(s)
13th Nov 20251:32 pmRNSDirector/PDMR Shareholding
13th Nov 20251:30 pmRNSDirector/PDMR Shareholding
7th Nov 202510:10 amRNSHolding(s) in Company
6th Nov 20251:51 pmRNSDirector/PDMR Shareholding
5th Nov 20255:48 pmRNSTR1 - Change in breakdown of voting rights
30th Oct 20257:00 amRNSResult of Tender Offer
24th Oct 202512:20 pmRNSResults of General Meeting
21st Oct 20257:01 amRNSDirector Appointments
21st Oct 20257:00 amRNSCapital Markets Day
29th Sep 20257:01 amRNSProposed Tender Offer and Notice of GM
29th Sep 20257:00 amRNSHalf Year Results
19th Sep 20257:00 amRNSAppointment of Chief Executive Officer
1st Sep 20253:37 pmRNSDirector/PDMR Shareholding
29th Aug 202512:52 pmRNSPDMR Dealing
28th Aug 20252:16 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSQuarterly Syndicate Mid-point Forecasts
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202512:12 pmRNSTR-1: Notification of major holdings
18th Jul 20257:00 amRNSResults of Scrip Dividend Election
9th Jul 20259:45 amRNSResults of Scrip Dividend Election
30th Jun 20255:40 pmRNSAppointment of Executive Director
30th Jun 202512:28 pmRNSResult of AGM
30th Jun 20257:00 amRNSChange of Nominated Adviser
20th Jun 20259:32 amRNSScrip Dividend Reference Price
9th Jun 20251:15 pmRNSLTIP Exercise and Total Voting Rights Update
9th Jun 20251:15 pmRNSGrant of LTIP Awards
2nd Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.